60 Degrees Pharmaceuticals, Inc. (SXTP) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$0.74
-23.95%
Mkt Cap $2.60M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | $320.00K | $300.00K | -6.25% | -$2.28 | -$1.91 | +16.23% |
| Q4 2025 Nov 13, 2025 | $200.00K | $437.60K | +118.80% | -$1.84 | -$2.64 | -43.48% |
| Q3 2025 Aug 13, 2025 | $150.00K | $100.93K | -32.71% | -$1.24 | -$1.25 | -0.81% |
| Q2 2025 May 15, 2025 | $300.00K | $163.55K | -45.48% | -$1.31 | -$1.56 | -19.08% |
| Q1 2025 Mar 27, 2025 | $250.00K | $261.44K | +4.58% | -$4.01 | -$14.20 | -254.11% |
| Q4 2024 Nov 14, 2024 | $250.00K | $135.29K | -45.88% | -$3.00 | -$4.65 | -55.00% |
| Q3 2024 Aug 14, 2024 | $100.00K | $124.97K | +24.97% | -$19.80 | -$21.15 | -6.82% |
| Q2 2024 May 15, 2024 | $134.50K | $105.67K | -21.43% | -$9.60 | $1.80 | +118.75% |
| Q2 2024 Apr 1, 2024 | $75.00K | $42.71K | -43.06% | -$16.21 | -$26.41 | -62.92% |
| Q4 2023 Nov 20, 2023 | $100.00K | $51.19K | -48.81% | -$15.61 | -$18.01 | -15.37% |
| Q3 2023 Aug 25, 2023 | — | $59.53K | — | — | -$1.40 | — |
| Q1 2023 Mar 31, 2023 | — | $17.17K | — | — | -$1.87 | — |
| Q4 2022 Dec 31, 2022 | — | -$75.65K | — | — | -$1.20 | — |
| Q3 2022 Sep 30, 2022 | — | $168.19K | — | — | -$1.04 | — |
| Q2 2022 Jun 30, 2022 | — | $45.17K | — | — | -$1.54 | — |
| Q1 2022 Mar 31, 2022 | — | $47.02K | — | — | -$37.68 | — |
| Q4 2021 Dec 31, 2021 | — | $286.64K | — | — | -$0.94 | — |